RADIOIMMUNOASSAY MEASUREMENT OF PROSTAGLANDIN-E2 AND PROSTAGLANDIN-F-2-ALPHA IN HUMAN-URINE

被引:115
作者
CIABATTONI, G
PUGLIESE, F
SPALDI, M
CINOTTI, GA
PATRONO, C
机构
[1] Department of Pharmacology, Catholic University, Rome, 00168
[2] Department of Medicine Ii, University of Rome, Rome
关键词
Bartter’s syndrome; furosemide; human urine; indomethacin; radioimmunoassay; Renal prostaglandins;
D O I
10.1007/BF03349310
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Techniques are described in detail for the radioimmunological measurement of prostaglandin (PG) E2 and F2α in human urine. 50 ml urine samples are extracted with an organic solvent system and then purified by silicic acid column chromatography. The overall recovery after extraction and purification, calculated with labeled as well as unlabeled compounds, is in the order of 70%. The column eluates are assayed at 1:12–1:60 dilution in the “standard diluent” of the assay: 8 pg PGE2.or PGF2a/ml of whole urine represents the lowest measurable concentration. A urine blank and a solvent blank were evaluated separately, subjecting 50 ml of urine obtained from an indomethacin treated subject (“PG-free” urine) or 50 ml of distilled water, respectively, to the extraction-purification procedures. Both were found not to interfere with the antigen-antibody reaction. Urinary PG-like immunoreactivity (LI) was characterized in terms of immunochemical and thin-layer chromatographic (TLC) behavior. Both urinary PGE2-LI and PGF2α-LI behaved as authentic PGE2 and PGF2α, upon dilution and on TLC. In 33 healthy female subjects (aged 19–58 yr), urinary excretion rates averaged 178 ± 80 (mean ± SD) ng/day for PGE2 and 498 ± 181 ng/day for PGF2α. In a group of 8 healthy men, both PGE2 and PGF2α crexcretion rates were higher and more scattered than the female values. When two healthy women were given indomethacin (200 mg/day), urinary PGE2 and PGF2α dropped to undetectable levels during the 4th day of drug therapy. I ntravenous injection of furosemide (50 mg) in a female volunteer was followed by an immediate rise of urinary sodium, PGE2, PGF2α and PGE2/PGF2α ratio and plasma renin activity. Ina 10 year old girl with Bartter’s syndrome, urinary PG excretion rate was elevated with a 3 times higher than normal PGE2/PGF2α ratio. Indomethacin therapy resulted in a prompt drop of PG excretion rate and of plasma renin activity. These results show that a combi nation of adequate purification steps and antisera with optimal characteristics provides a reliable method for measuring PGE2 and PGF2α in urine, and therefore a valuable tool to further our knowledge of the physiology and physiopathology of the renal PG-system. © 1978, Italian Society of Endocrinology (SIE). All rights reserved.
引用
收藏
页码:173 / 182
页数:10
相关论文
共 28 条
  • [21] Scherer B., Schnermann J., Sofroniev M., Weber PC Prostaglandin (PG) analysis in urine of humans and rats by different radioimmunoassays: effect on PG-excretion by PG-synthetase inhibitors, laparotomy and furosemide, Prostaglandins, 75, (1978)
  • [22] Pace-Asciak C.R., Wolfe L.S., A novel prostaglandin derivative formed from arachidonic acid by rat stomach homogenate, Biochemistry, 10, (1971)
  • [23] Patrono C., Ciabattoni G., Cinotti G.A., Pugliese F., De Salvo A., Castrucci G., Characterization of human urinary prostaglandin-like immunoreactivity, Prostaglandins, 15, (1978)
  • [24] Perry D.L., Desiderio D.M., Utility of d<sub>4</sub>-PGE<sub>2</sub> as an internal standard to quantify endogenous levels of PGE<sub>1</sub>, PGE<sub>2</sub>, 190H PGE<sub>1</sub>( and 190H PGE<sub>2</sub> in human seminal fluid by GC-MS-SIM, Prostaglandins, 14, (1977)
  • [25] Yalow R.S., Berson S.A., Problems of validation of radioimmunoassay, Principles of competitive protein-binding assays, (1971)
  • [26] Weber P.C., Larsson C., Anggard E., Hamberg M., Corey E.J., Nicolau K.C., Samuelsson B., Stimulation of renin release from rabbit renal cortex by arachidonic acid and prostaglandin endoperoxides, Circulat. Res., 39, (1976)
  • [27] Stone K.J., Hart M., Inhibition of renal PGE<sub>2</sub>-9-ketoreductase by diuretics, Prostaglandins, 12, (1976)
  • [28] Weber P.C., Larsson C., Scherer B., Prostaglandin E<sub>2</sub>-9-ketoreductase as a mediator of salt intake-related prostaglandin-renin interaction, Nature, 266, (1977)